Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jessica Braid"'
Autor:
Christine Manta Campbell, Courtney Webster, Megan Parisi, Roya Sherafat-Kazemzadeh, Jessica Braid, Thomas Switzer, Marcelo Alves Fávaro, Caprice Sassano, Andrea Coravos
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-5 (2024)
Abstract Regulators increasingly require clinical outcome assessment (COA) data for approval. COAs can be collected via questionnaires or digital health technologies (DHTs), yet no single resource provides a side-by-side comparison of tools that coll
Externí odkaz:
https://doaj.org/article/aeef37ba92b54efebb5f6c56ef688bb1
Autor:
Jessica Braid
Publikováno v:
Neurology and Therapy, Vol 13, Iss 1, Pp 251-254 (2023)
Externí odkaz:
https://doaj.org/article/6e68e85675e7498faf26f5f3df29bc53
Autor:
Jessica Braid, MS, Lutaf Islam, DVM, Cristian Gugiu, PhD, Theodore A. Omachi, MD, Helen Doll, BSc
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 5, Pp 100776- (2023)
Objective: Nasal Polyp Score (NPS) and Nasal Congestion Score (NCS) are commonly used clinical trial endpoints to determine improvements in response to treatment in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). However, limited inf
Externí odkaz:
https://doaj.org/article/d3a10e5450164f8aa4946c3cca511cb7
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/3e7969a63e0b479d964476d929ecea58
Autor:
Tina Duong, Jessica Braid, Hannah Staunton, Aurelie Barriere, Fani Petridis, Johannes Reithinger, Rosangel Cruz, Jill Jarecki, Mencia De Lemus, Nicole Gusset, Ria Broekgaarden, Sharan Randhawa, Jessica Flynn, Rob Arbuckle, Sonia Reif, Lida Yang, Angela De Martini, Carole Vuillerot
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-pa
Externí odkaz:
https://doaj.org/article/40a4d4e72db647e4b617a358a6c10774
Autor:
Tina Duong, Hannah Staunton, Jessica Braid, Aurelie Barriere, Ben Trzaskoma, Ling Gao, Tom Willgoss, Rosangel Cruz, Nicole Gusset, Ksenija Gorni, Sharan Randhawa, Lida Yang, Carole Vuillerot
Publikováno v:
Frontiers in Neurology, Vol 12 (2022)
The 32-item Motor Function Measure (MFM32) is an assessment of motor function used to evaluate fine and gross motor ability in patients with neuromuscular disorders, including spinal muscular atrophy (SMA). Reliability and validity of the MFM32 have
Externí odkaz:
https://doaj.org/article/bfda0d067a5e46119881b84dee5d1662
Autor:
Laurent Servais, Maryam Oskoui, John Day, Nicholas Deconinck, Elena Mazzone, Andrés Nascimento, Kyoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug-Tanguy, Nathalie Goemans, Janbernd Kirschner, Anna Kostera-Pruszczyk, Jessica Braid, Gergely Papp, Ksenija Gorni, Carmen Martin, Renata Scalco, Wai Yin Yeung, Eugenio Mercuri
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bfd5ad7b2da93cbab542167ff846ef7
https://doi.org/10.1212/wnl.0000000000203570
https://doi.org/10.1212/wnl.0000000000203570
Autor:
Joseph K, Han, Bongin, Yoo, Rebecca, Saenz, Jessica, Braid, Lauren A, Millette, Stella E, Lee
Publikováno v:
International Forum of Allergy & Rhinology. 12:1188-1190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f26ae02dabc5962f84f990356143d70
https://doi.org/10.1002/alr.22963
https://doi.org/10.1002/alr.22963
Autor:
Patricia K Corey-Lisle, Jessica Braid, Susanne Clinch, Siobhan Connor, Hannah Staunton, Bruno Kovic, T.G. Willgoss, Teofil Ciobanu
PurposeMethods for deriving clinically meaningful change thresholds have advanced considerably in recent years, however, key questions remain about what the identified change score actually means for an individual patient or group of patient. This is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::049498b0fdab18208174c682f315abcc
https://doi.org/10.21203/rs.3.rs-386476/v1
https://doi.org/10.21203/rs.3.rs-386476/v1
Autor:
Fani Petridis, Lida Yang, Jessica Flynn, Jill Jarecki, Angela De Martini, Johannes Reithinger, Rob Arbuckle, Ria Broekgaarden, Sonia Reif, Hannah Staunton, Tina Duong, Aurelie Barriere, Carole Vuillerot, Nicole Gusset, Jessica Braid, Sharan Randhawa, Mencia de Lemus, Rosangel Cruz
Publikováno v:
BMC Neurology
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Neurology, BioMed Central, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, 2021, 21 (1), pp.143. ⟨10.1186/s12883-021-02166-z⟩
BMC Neurology, Vol 21, Iss 1, Pp 1-14 (2021)
Background The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular diseases, including those with spinal muscular atrophy (SMA). This two-part study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527932df41f923d6b9d4fa7442fdada2
https://www.hal.inserm.fr/inserm-03310641
https://www.hal.inserm.fr/inserm-03310641